These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 23229294)
1. Synergistic apoptotic effect of celecoxib and luteolin on breast cancer cells. Jeon YW; Suh YJ Oncol Rep; 2013 Feb; 29(2):819-25. PubMed ID: 23229294 [TBL] [Abstract][Full Text] [Related]
2. Overcoming trastuzumab resistance in HER2-overexpressing breast cancer cells by using a novel celecoxib-derived phosphoinositide-dependent kinase-1 inhibitor. Tseng PH; Wang YC; Weng SC; Weng JR; Chen CS; Brueggemeier RW; Shapiro CL; Chen CY; Dunn SE; Pollak M; Chen CS Mol Pharmacol; 2006 Nov; 70(5):1534-41. PubMed ID: 16887935 [TBL] [Abstract][Full Text] [Related]
3. Involvement of mitochondrial and Akt signaling pathways in augmented apoptosis induced by a combination of low doses of celecoxib and N-(4-hydroxyphenyl) retinamide in premalignant human bronchial epithelial cells. Schroeder CP; Kadara H; Lotan D; Woo JK; Lee HY; Hong WK; Lotan R Cancer Res; 2006 Oct; 66(19):9762-70. PubMed ID: 17018636 [TBL] [Abstract][Full Text] [Related]
4. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455 [TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer. Barnes NL; Warnberg F; Farnie G; White D; Jiang W; Anderson E; Bundred NJ Br J Cancer; 2007 Feb; 96(4):575-82. PubMed ID: 17285134 [TBL] [Abstract][Full Text] [Related]
6. Synergistic tumoricidal effect between celecoxib and adenoviral-mediated delivery of mda-7 in human breast cancer cells. Suh YJ; Chada S; McKenzie T; Liu Y; Swisher SG; Lucci A; Hunt KK Surgery; 2005 Sep; 138(3):422-30. PubMed ID: 16213894 [TBL] [Abstract][Full Text] [Related]
7. Synergistic effect between celecoxib and luteolin is dependent on estrogen receptor in human breast cancer cells. Jeon YW; Ahn YE; Chung WS; Choi HJ; Suh YJ Tumour Biol; 2015 Aug; 36(8):6349-59. PubMed ID: 25851346 [TBL] [Abstract][Full Text] [Related]
8. AEE788 potentiates celecoxib-induced growth inhibition and apoptosis in human colon cancer cells. Venkatesan P; Bhutia SK; Singh AK; Das SK; Dash R; Chaudhury K; Sarkar D; Fisher PB; Mandal M Life Sci; 2012 Oct; 91(15-16):789-99. PubMed ID: 22922496 [TBL] [Abstract][Full Text] [Related]
9. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt. Liu B; Shi ZL; Feng J; Tao HM Cell Biol Int; 2008 May; 32(5):494-501. PubMed ID: 18078766 [TBL] [Abstract][Full Text] [Related]
10. Effects of celecoxib treatment over the AKT pathway in head and neck squamous cell carcinoma. Abrahão AC; Giudice FS; Sperandio FF; Pinto Junior Ddos S J Oral Pathol Med; 2013 Nov; 42(10):793-8. PubMed ID: 23679684 [TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer. Basu GD; Pathangey LB; Tinder TL; Lagioia M; Gendler SJ; Mukherjee P Mol Cancer Res; 2004 Nov; 2(11):632-42. PubMed ID: 15561779 [TBL] [Abstract][Full Text] [Related]
12. [Effects of a selective cyclooxygenase 2 inhibitor celecoxib on the proliferation and apoptosis of human prostate cancer cell line PC-3]. Xu S; Zhou WQ; Zhang ZY; Ge JP; Gao JP Zhonghua Nan Ke Xue; 2008 Jun; 14(6):489-93. PubMed ID: 18649743 [TBL] [Abstract][Full Text] [Related]
13. Radiosensitivity enhancement by combined treatment of celecoxib and gefitinib on human lung cancer cells. Park JS; Jun HJ; Cho MJ; Cho KH; Lee JS; Zo JI; Pyo H Clin Cancer Res; 2006 Aug; 12(16):4989-99. PubMed ID: 16914589 [TBL] [Abstract][Full Text] [Related]
14. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib. Zhang GS; Liu DS; Dai CW; Li RJ Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells. Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447 [TBL] [Abstract][Full Text] [Related]
16. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib. Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760 [TBL] [Abstract][Full Text] [Related]
17. Combining celecoxib with sorafenib synergistically inhibits hepatocellular carcinoma cells in vitro. Morisaki T; Umebayashi M; Kiyota A; Koya N; Tanaka H; Onishi H; Katano M Anticancer Res; 2013 Apr; 33(4):1387-95. PubMed ID: 23564777 [TBL] [Abstract][Full Text] [Related]
18. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1. Arunasree KM; Roy KR; Anilkumar K; Aparna A; Reddy GV; Reddanna P Leuk Res; 2008 Jun; 32(6):855-64. PubMed ID: 18083230 [TBL] [Abstract][Full Text] [Related]
19. [Celecoxib increased cellular ATRA sensitivity of human colon cancer cell lines through COX-2-independent mechanisms]. Liu JP; Wei HB; Zheng ZH; Guo WP; Fang JF Yao Xue Xue Bao; 2009 Dec; 44(12):1353-8. PubMed ID: 21351468 [TBL] [Abstract][Full Text] [Related]
20. Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells. Sugimoto T; Bartholomeusz C; Tari AM; Ueno NT Breast Cancer Res; 2007; 9(4):R41. PubMed ID: 17612393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]